Responses
Editorial
Chemotherapy for advanced lung cancer: is the glass half full or half empty?
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 November 2004
- Published on: 18 November 2004Using the Number Needed to Treat to Make Decisions About Chemotherapy for Lung CancerShow More
Dear Editor
Like Dr. Silvestri, I support a model of shared decision making when considering chemotherapy [1]. Unfortunately, many patients don’t realize that the advantages of chemotherapy are not shared equally by those treated. For example, Spiro et al. show that chemotherapy reduces the risk of death from lung cancer by 9% and 5% at one and two years, respectively [2]. The fact that the reduction benefits o...
Conflict of Interest:
None declared.